They're usually being seen either by my colleagues and gastroenterology or medical oncology. With that, unfortunately, many patients don't end up. It is often a poor prognosis, mainly because, as you can imagine, your stomach is kind of like a balloon a bag, and so patients don't often present until later on another disease. Since you've reviewed the statistics, isn't it true that gastric cancer or stomach cancer is also associated with a pretty poor prognosis? That's exactly right. So they're really getting that holistic care.

And so we wanted to do was bring together those experts across the enterprise that focus on this disease and provide a comprehensive way of managing thes patients. With that, we find it's kind of an orphan cancer in a lot of places. And with that, about 11,000 patients succumb to this disease. Gastric cancer is actually, um, not a very prevalent cancer is only about 30,000 cases per year. How long has this program been around? Well, this program is actually very new program, but we realized we needed something different. I think we'd like to start with the idea of a multi disciplinary approach to the treatment of stomach cancer. I'm a surgical oncologist on so winning, I'm lumping I'm a gastroenterologist. I'm a medical oncologist, Fabian Johnson.

Welcome to our panel discussion on a multi disciplinary approach to the treatment of stomach cancer from Johns Hopkins Medicine. The Johns Hopkins stomach (gastric) cancer multidisciplinary team participates in an in-depth podcast about innovative research, a collaborative approach to stomach cancer treatment and the program’s benefits to patients.

Hey eliza cancer type